Globeflex Capital L P Ovid Therapeutics Inc. Transaction History

Globeflex Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.31 $2.21 Million - $4.32 Million	-1,305,588 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.65 - $3.49 $243,346 - $320,483	-91,829 Reduced 6.57%	1,305,588 $4.1 Million
Q4 2021 Feb 10, 2022	SELL	$3.13 - $3.73 $1,104 - $1,316	-353 Reduced 0.03%	1,397,417 $4.49 Million
Q3 2021 Nov 12, 2021	BUY	$3.31 - $4.04 $1.29 Million - $1.57 Million	388,645 Added 38.51%	1,397,770 $4.7 Million
Q2 2021 Aug 12, 2021	BUY	$3.3 - $4.49 $3.33 Million - $4.53 Million	1,009,125 New	1,009,125 $3.95 Million

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.